New blastic plasmacytoid dendritic cell neoplasm (BPDCN) treatment improves outlook for many patients
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare type of acute leukemia that impacts about 500-1,000 people in the U.S. each year. It mainly affects older patients, but can affect people of any age.
Blastic plasmacytoid dendritic cell neoplasm springs from a rare immune cell that is usually found in the skin, bone marrow, blood, lymph nodes and spleen. Because it affects almost every part of the body and its name...
Hereditary leukemia syndromes: What patients and their families should know
Certain genetic changes, or mutations, can increase a person’s chances of developing cancer. These changes, known as hereditary cancer syndromes...